HEADER OXIDOREDUCTASE 14-MAY-17 5NZO TITLE CRYSTAL STRUCTURE OF HUMAN 3-PHOSPHOGLYCERATE DEHYDROGENASE IN COMPLEX TITLE 2 WITH 1-METHYL-3-PHENYL-1H-PYRAZOL-5-AMINE COMPND MOL_ID: 1; COMPND 2 MOLECULE: D-3-PHOSPHOGLYCERATE DEHYDROGENASE; COMPND 3 CHAIN: B, A; COMPND 4 SYNONYM: 3-PGDH,2-OXOGLUTARATE REDUCTASE,MALATE DEHYDROGENASE; COMPND 5 EC: 1.1.1.95,1.1.1.399,1.1.1.37; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: PHGDH, PGDH3; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS DEHYDROGENASE, SERINE METABOLISM, FBDD, OXIDOREDUCTASE EXPDTA X-RAY DIFFRACTION AUTHOR J.E.UNTERLASS,A.BASLE,T.J.BLACKBURN,J.TUCKER,C.CANO,M.E.M.NOBLE, AUTHOR 2 N.J.CURTIN REVDAT 6 17-JAN-24 5NZO 1 REMARK REVDAT 5 10-JUL-19 5NZO 1 REMARK REVDAT 4 20-FEB-19 5NZO 1 REMARK LINK REVDAT 3 04-APR-18 5NZO 1 JRNL REVDAT 2 30-AUG-17 5NZO 1 REMARK REVDAT 1 14-JUN-17 5NZO 0 JRNL AUTH J.E.UNTERLASS,A.BASLE,T.J.BLACKBURN,J.TUCKER,C.CANO, JRNL AUTH 2 M.E.M.NOBLE,N.J.CURTIN JRNL TITL VALIDATING AND ENABLING PHOSPHOGLYCERATE DEHYDROGENASE JRNL TITL 2 (PHGDH) AS A TARGET FOR FRAGMENT-BASED DRUG DISCOVERY IN JRNL TITL 3 PHGDH-AMPLIFIED BREAST CANCER. JRNL REF ONCOTARGET V. 9 13139 2018 JRNL REFN ESSN 1949-2553 JRNL PMID 29568346 JRNL DOI 10.18632/ONCOTARGET.11487 REMARK 2 REMARK 2 RESOLUTION. 1.29 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0135 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.29 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 49.88 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 79.1 REMARK 3 NUMBER OF REFLECTIONS : 70307 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.198 REMARK 3 R VALUE (WORKING SET) : 0.196 REMARK 3 FREE R VALUE : 0.241 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.900 REMARK 3 FREE R VALUE TEST SET COUNT : 3651 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.29 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.32 REMARK 3 REFLECTION IN BIN (WORKING SET) : 2316 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 35.11 REMARK 3 BIN R VALUE (WORKING SET) : 0.3280 REMARK 3 BIN FREE R VALUE SET COUNT : 119 REMARK 3 BIN FREE R VALUE : 0.3500 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2920 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 26 REMARK 3 SOLVENT ATOMS : 272 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 20.25 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.12000 REMARK 3 B22 (A**2) : -0.20000 REMARK 3 B33 (A**2) : -0.89000 REMARK 3 B12 (A**2) : 0.79000 REMARK 3 B13 (A**2) : -0.20000 REMARK 3 B23 (A**2) : 1.68000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.081 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.075 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.077 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 4.366 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.959 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.943 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 3173 ; 0.019 ; 0.019 REMARK 3 BOND LENGTHS OTHERS (A): 3095 ; 0.008 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 4308 ; 1.962 ; 1.971 REMARK 3 BOND ANGLES OTHERS (DEGREES): 7149 ; 1.467 ; 2.992 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 425 ; 6.804 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 125 ;36.619 ;24.400 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 569 ;14.362 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 23 ;16.725 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 483 ; 0.132 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 3690 ; 0.012 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): 695 ; 0.006 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): 6268 ; 4.261 ; 3.000 REMARK 3 SPHERICITY; FREE ATOMS (A**2): 69 ;38.383 ; 5.000 REMARK 3 SPHERICITY; BONDED ATOMS (A**2): 6405 ;19.943 ; 5.000 REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NCS TYPE: LOCAL REMARK 3 NUMBER OF DIFFERENT NCS PAIRS : 1 REMARK 3 GROUP CHAIN1 RANGE CHAIN2 RANGE COUNT RMS WEIGHT REMARK 3 1 B 100 294 A 100 294 23218 0.080 0.050 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS U VALUES : REFINED INDIVIDUALLY REMARK 4 REMARK 4 5NZO COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 15-MAY-17. REMARK 100 THE DEPOSITION ID IS D_1200003526. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 22-OCT-14 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I04-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.920 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 S 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XIA2 REMARK 200 DATA SCALING SOFTWARE : XIA2 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 73976 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.290 REMARK 200 RESOLUTION RANGE LOW (A) : 49.900 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 82.8 REMARK 200 DATA REDUNDANCY : 1.940 REMARK 200 R MERGE (I) : 0.09100 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 4.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.31 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.33 REMARK 200 COMPLETENESS FOR SHELL (%) : 84.2 REMARK 200 DATA REDUNDANCY IN SHELL : 1.90 REMARK 200 R MERGE FOR SHELL (I) : 0.91700 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 2G76 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 45.71 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.27 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M PCTP BUFFER, PH 7 AND 23-28 % REMARK 280 (W/V) PEG 1500, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4940 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 15090 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -31.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 ND2 ASN A 220 O HOH B 407 1444 0.99 REMARK 500 CG ASN A 220 O HOH B 407 1444 2.17 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG B 236 NE - CZ - NH1 ANGL. DEV. = 3.2 DEGREES REMARK 500 ARG A 236 NE - CZ - NH1 ANGL. DEV. = 4.0 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLU B 134 74.21 -116.01 REMARK 500 HIS B 206 55.02 -140.88 REMARK 500 ALA B 235 -84.47 -104.23 REMARK 500 GLU A 134 66.01 -119.76 REMARK 500 HIS A 206 53.95 -142.77 REMARK 500 ALA A 235 -81.82 -103.44 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 9EZ B 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 9EZ A 301 DBREF 5NZO B 100 294 UNP O43175 SERA_HUMAN 100 294 DBREF 5NZO A 100 294 UNP O43175 SERA_HUMAN 100 294 SEQRES 1 B 195 ASN GLY ASN SER LEU SER ALA ALA GLU LEU THR CYS GLY SEQRES 2 B 195 MET ILE MET CYS LEU ALA ARG GLN ILE PRO GLN ALA THR SEQRES 3 B 195 ALA SER MET LYS ASP GLY LYS TRP GLU ARG LYS LYS PHE SEQRES 4 B 195 MET GLY THR GLU LEU ASN GLY LYS THR LEU GLY ILE LEU SEQRES 5 B 195 GLY LEU GLY ARG ILE GLY ARG GLU VAL ALA THR ARG MET SEQRES 6 B 195 GLN SER PHE GLY MET LYS THR ILE GLY TYR ASP PRO ILE SEQRES 7 B 195 ILE SER PRO GLU VAL SER ALA SER PHE GLY VAL GLN GLN SEQRES 8 B 195 LEU PRO LEU GLU GLU ILE TRP PRO LEU CYS ASP PHE ILE SEQRES 9 B 195 THR VAL HIS THR PRO LEU LEU PRO SER THR THR GLY LEU SEQRES 10 B 195 LEU ASN ASP ASN THR PHE ALA GLN CYS LYS LYS GLY VAL SEQRES 11 B 195 ARG VAL VAL ASN CYS ALA ARG GLY GLY ILE VAL ASP GLU SEQRES 12 B 195 GLY ALA LEU LEU ARG ALA LEU GLN SER GLY GLN CYS ALA SEQRES 13 B 195 GLY ALA ALA LEU ASP VAL PHE THR GLU GLU PRO PRO ARG SEQRES 14 B 195 ASP ARG ALA LEU VAL ASP HIS GLU ASN VAL ILE SER CYS SEQRES 15 B 195 PRO HIS LEU GLY ALA SER THR LYS GLU ALA GLN SER ARG SEQRES 1 A 195 ASN GLY ASN SER LEU SER ALA ALA GLU LEU THR CYS GLY SEQRES 2 A 195 MET ILE MET CYS LEU ALA ARG GLN ILE PRO GLN ALA THR SEQRES 3 A 195 ALA SER MET LYS ASP GLY LYS TRP GLU ARG LYS LYS PHE SEQRES 4 A 195 MET GLY THR GLU LEU ASN GLY LYS THR LEU GLY ILE LEU SEQRES 5 A 195 GLY LEU GLY ARG ILE GLY ARG GLU VAL ALA THR ARG MET SEQRES 6 A 195 GLN SER PHE GLY MET LYS THR ILE GLY TYR ASP PRO ILE SEQRES 7 A 195 ILE SER PRO GLU VAL SER ALA SER PHE GLY VAL GLN GLN SEQRES 8 A 195 LEU PRO LEU GLU GLU ILE TRP PRO LEU CYS ASP PHE ILE SEQRES 9 A 195 THR VAL HIS THR PRO LEU LEU PRO SER THR THR GLY LEU SEQRES 10 A 195 LEU ASN ASP ASN THR PHE ALA GLN CYS LYS LYS GLY VAL SEQRES 11 A 195 ARG VAL VAL ASN CYS ALA ARG GLY GLY ILE VAL ASP GLU SEQRES 12 A 195 GLY ALA LEU LEU ARG ALA LEU GLN SER GLY GLN CYS ALA SEQRES 13 A 195 GLY ALA ALA LEU ASP VAL PHE THR GLU GLU PRO PRO ARG SEQRES 14 A 195 ASP ARG ALA LEU VAL ASP HIS GLU ASN VAL ILE SER CYS SEQRES 15 A 195 PRO HIS LEU GLY ALA SER THR LYS GLU ALA GLN SER ARG HET 9EZ B 301 13 HET 9EZ A 301 13 HETNAM 9EZ 2-METHYL-5-PHENYL-PYRAZOL-3-AMINE FORMUL 3 9EZ 2(C10 H11 N3) FORMUL 5 HOH *272(H2 O) HELIX 1 AA1 ASN B 102 GLN B 120 1 19 HELIX 2 AA2 GLN B 120 ASP B 130 1 11 HELIX 3 AA3 GLY B 154 SER B 166 1 13 HELIX 4 AA4 SER B 179 PHE B 186 1 8 HELIX 5 AA5 PRO B 192 TRP B 197 1 6 HELIX 6 AA6 PRO B 198 CYS B 200 5 3 HELIX 7 AA7 LEU B 210 THR B 214 5 5 HELIX 8 AA8 ASN B 218 ALA B 223 1 6 HELIX 9 AA9 ASP B 241 GLY B 252 1 12 HELIX 10 AB1 ARG B 270 HIS B 275 1 6 HELIX 11 AB2 THR B 288 SER B 293 1 6 HELIX 12 AB3 ASN A 102 GLN A 120 1 19 HELIX 13 AB4 GLN A 120 ASP A 130 1 11 HELIX 14 AB5 GLY A 154 SER A 166 1 13 HELIX 15 AB6 SER A 179 SER A 185 1 7 HELIX 16 AB7 PRO A 192 TRP A 197 1 6 HELIX 17 AB8 PRO A 198 CYS A 200 5 3 HELIX 18 AB9 ASN A 218 ALA A 223 1 6 HELIX 19 AC1 ASP A 241 GLY A 252 1 12 HELIX 20 AC2 ARG A 270 HIS A 275 1 6 HELIX 21 AC3 THR A 288 SER A 293 1 6 SHEET 1 AA1 7 GLN B 189 GLN B 190 0 SHEET 2 AA1 7 LYS B 170 TYR B 174 1 N GLY B 173 O GLN B 189 SHEET 3 AA1 7 THR B 147 LEU B 151 1 N LEU B 148 O LYS B 170 SHEET 4 AA1 7 PHE B 202 VAL B 205 1 O PHE B 202 N GLY B 149 SHEET 5 AA1 7 VAL B 229 ASN B 233 1 O VAL B 232 N ILE B 203 SHEET 6 AA1 7 CYS B 254 LEU B 259 1 O ALA B 258 N ASN B 233 SHEET 7 AA1 7 VAL B 278 SER B 280 1 O ILE B 279 N LEU B 259 SHEET 1 AA2 7 GLN A 189 GLN A 190 0 SHEET 2 AA2 7 LYS A 170 TYR A 174 1 N GLY A 173 O GLN A 189 SHEET 3 AA2 7 THR A 147 LEU A 151 1 N LEU A 148 O LYS A 170 SHEET 4 AA2 7 PHE A 202 VAL A 205 1 O PHE A 202 N GLY A 149 SHEET 5 AA2 7 VAL A 229 ASN A 233 1 O VAL A 232 N ILE A 203 SHEET 6 AA2 7 CYS A 254 LEU A 259 1 O ALA A 258 N ASN A 233 SHEET 7 AA2 7 VAL A 278 SER A 280 1 O ILE A 279 N ALA A 257 CISPEP 1 GLU B 265 PRO B 266 0 -9.96 CISPEP 2 GLU A 265 PRO A 266 0 -10.50 SITE 1 AC1 7 GLY B 152 TYR B 174 PRO B 176 THR B 207 SITE 2 AC1 7 PRO B 208 LEU B 210 THR B 213 SITE 1 AC2 6 TYR A 174 PRO A 176 THR A 207 PRO A 208 SITE 2 AC2 6 LEU A 210 THR A 213 CRYST1 43.391 45.783 54.807 97.05 110.12 106.65 P 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.023046 0.006894 0.010459 0.00000 SCALE2 0.000000 0.022799 0.005785 0.00000 SCALE3 0.000000 0.000000 0.020047 0.00000